Cellular Respiration during Hypoxia
ROLE OF CYTOCHROME OXIDASE AS THE OXYGEN SENSOR IN HEPATOCYTES*
- From the Department of Medicine, Section of Pulmonary and Critical Care, the University of Chicago, Chicago, Illinois 60637
Abstract
We previously reported that hepatocytes exhibit a reversible suppression of respiration during prolonged hypoxia (PO2 = 20 torr for 3–5 h). Also, isolated bovine heart cytochrome c oxidase undergoes a reversible decrease in apparent V max when incubated under similar conditions. This study sought to link the hypoxia-induced changes in cytochrome oxidase to the inhibition of respiration seen in intact cells. Hepatocytes incubated at PO2 = 20 torr exhibited decreases in respiration and increases in [NAD(P)H] after 2–3 h that were reversed upon reoxygenation (PO2 = 100 torr). Respiration during hypoxia was also inhibited whenN,N,N′,N′-tetramethyl-p-phenylenediamine (0.5 mm) and ascorbate (5 mm) were used to reduce cytochrome c, suggesting that cytochrome oxidase was partially inhibited. Similarly, liver submitochondrial particles revealed a 44% decrease in the apparent V maxof cytochrome oxidase after hypoxic incubation. In hepatocytes loaded with tetramethylrhodamine ethyl ester (10 nm) to quantify mitochondrial membrane potential, acute hypoxia (<30 min) produced no change in fluorescence, consistent with the absence of an acute change in respiration. However, fluorescence increased during acute reoxygenation after prolonged hypoxia, suggesting an increase in potential. The control exhibited by NADH over mitochondrial respiration was not altered during hypoxia. Thus, changes in theV max of cytochrome oxidase during prolonged hypoxia correlate with the changes in respiration and mitochondrial potential. This suggests that the oxidase functions as an oxygen sensor in the intact hepatocyte.
Footnotes
-
↵* This work was supported by NHLBI, National Institutes of Health Grants HL32646 and HL35440.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵‡ To whom correspondence should be addressed: Pulmonary and Critical Care Medicine, the University of Chicago, MC6026, 5841 South Maryland Ave., Chicago, IL 60637. Tel.: 773-702-9363; Fax: 773-702-4736; E-mail:pschumac{at}medicine.bsd.uchicago.edu.
-
↵1 The abbreviation used is: TMPD,N,N,N′,N′-tetramethyl-p-phenylenediamine.
-
- Received December 23, 1996.
- Revision received April 21, 1997.










